Patents by Inventor Meenakshi S. Venkatraman

Meenakshi S. Venkatraman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treprostinil derivative compounds and methods of using same
    Patent number: 9371264
    Abstract: Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable treatment dosage. Transdermal applications can be used.
    Type: Grant
    Filed: January 13, 2014
    Date of Patent: June 21, 2016
    Assignee: CORSAIR PHARMA, INC.
    Inventors: Cyrus K. Becker, Jürg R. Pfister, Gwenaella Rescourio, Meenakshi S. Venkatraman, Xiaoming Zhang
  • 7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof
    Patent number: 9320731
    Abstract: Muscarinic acetylcholine receptor antagonists and methods of using them for the treatment of muscarinic acetylcholine receptor-mediated diseases, such as pulmonary diseases, are provided.
    Type: Grant
    Filed: April 14, 2014
    Date of Patent: April 26, 2016
    Assignee: THERON PHARMACEUTICALS, INC.
    Inventors: Jürg R. Pfister, Gwenaella Rescourio, Meenakshi S. Venkatraman, Xiaoming Zhang
  • TREPROSTINIL DERIVATIVE COMPOUNDS AND METHODS OF USING SAME
    Publication number: 20150166503
    Abstract: Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable treatment dosage. Transdermal applications can be used.
    Type: Application
    Filed: July 16, 2014
    Publication date: June 18, 2015
    Inventors: Cyrus K. BECKER, Jürg R. PFISTER, Gwenaella RESCOURIO, Meenakshi S. VENKATRAMAN, Xiaoming ZHANG
  • TREPROSTINIL DERIVATIVE COMPOUNDS AND METHODS OF USING SAME
    Publication number: 20140256730
    Abstract: Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable treatment dosage. Transdermal applications can be used.
    Type: Application
    Filed: January 13, 2014
    Publication date: September 11, 2014
    Applicant: Corsair Pharma, Inc.
    Inventors: Cyrus K. BECKER, Jürg R. PFISTER, Gwenaella RESCOURIO, Meenakshi S. VENKATRAMAN, Xiaoming ZHANG
  • 7-AZONIABICYCLO[2.2.1]HEPTANE DERIVATIVES, METHODS OF PRODUCTION, AND PHARMACEUTICAL USES THEREOF
    Publication number: 20140249195
    Abstract: Muscarinic acetylcholine receptor antagonists and methods of using them for the treatment of muscarinic acetylcholine receptor-mediated diseases, such as pulmonary diseases, are provided
    Type: Application
    Filed: April 14, 2014
    Publication date: September 4, 2014
    Applicant: THERON PHARMACEUTICALS, INC
    Inventors: Jürg R. PFISTER, Gwenaella RESCOURIO, Meenakshi S. VENKATRAMAN, Xiaoming ZHANG
  • 7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof
    Patent number: 8742134
    Abstract: Muscarinic acetylcholine receptor antagonists and methods of using them for the treatment of muscarinic acetylcholine receptor-mediated diseases, such as pulmonary diseases, are provided.
    Type: Grant
    Filed: December 20, 2012
    Date of Patent: June 3, 2014
    Assignee: Theron Pharmaceuticals, Inc.
    Inventors: Jurg R. Pfister, Gwenaella Rescourio, Meenakshi S. Venkatraman, Xiaoming Zhang
  • 7-azoniabicyclo [2.2.1] heptane derivatives, methods of production, and pharmaceutical uses thereof
    Patent number: 8742131
    Abstract: Muscarinic acetylcholine receptor antagonists and methods of using them for the treatment of muscarinic acetyl-choline receptor-mediated diseases, such as pulmonary diseases, are provided.
    Type: Grant
    Filed: January 27, 2011
    Date of Patent: June 3, 2014
    Assignee: Theron Pharmaceuticals, Inc.
    Inventors: Jürg R. Pfister, Gwenaella Rescourio, Meenakshi S. Venkatraman, Xiaoming Zhang
  • 7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof
    Patent number: 8426611
    Abstract: Muscarinic acetylcholine receptor antagonists and methods of using them for the treatment of muscarinic acetylcholine receptor-mediated diseases, such as pulmonary diseases, are provided.
    Type: Grant
    Filed: January 27, 2011
    Date of Patent: April 23, 2013
    Assignee: Theron Pharmaceuticals Inc.
    Inventors: Jürg R. Pfister, Gwenaella Rescourio, Meenakshi S. Venkatraman, Xiaoming Zhang
  • 7-AZONIABICYCLO [2.2.1] HEPTANE DERIVATIVES, METHODS OF PRODUCTION, AND PHARMACEUTICAL USES THEREOF
    Publication number: 20130059898
    Abstract: Muscarinic acetylcholine receptor antagonists and methods of using them for the treatment of muscarinic acetyl-choline receptor-mediated diseases, such as pulmonary diseases, are provided.
    Type: Application
    Filed: January 27, 2011
    Publication date: March 7, 2013
    Applicant: Theron Pharmaceuticals, Inc.
    Inventors: Jürg R. Pfister, Gwenaella Rescourio, Meenakshi S. Venkatraman, Xiaoming Zhang
  • Compositions and methods for inhibiting TGF-?
    Patent number: 8268857
    Abstract: This invention provides compounds that are useful for treating patients having a TGF-?-mediated disease, particularly an ALK5-mediated disease. The compounds are represented by formula I: wherein: a-b is CH2CH2, CH2CH2CH2, CH?CH, CH?N, or N?CH; Z is N or C—F; and G is C1-6 aliphatic or a phenyl, naphthyl, or 5-6 membered heteroaryl ring.
    Type: Grant
    Filed: January 16, 2007
    Date of Patent: September 18, 2012
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Robert M. Scarborough, Anjali Pandey, Meenakshi S. Venkatraman
  • 4-substituted quinuclidine derivatives, methods of production, pharmaceutical uses thereof
    Patent number: 8114891
    Abstract: The present invention relates to compounds and formulations capable of affecting nicotinic acetylcholine receptors (nAChRs), for example, as modulators of specific nicotinic receptor subtypes (specifically, the alpha7 nAChR subtype). The present invention also relates to methods for treating a wide variety of conditions and disorders, particularly those associated with dysfunction of the central and autonomic nervous systems.
    Type: Grant
    Filed: September 30, 2008
    Date of Patent: February 14, 2012
    Assignee: CoMentis, Inc.
    Inventors: Jürg R. Pfister, Meenakshi S. Venkatraman, Xiaoming Zhang
  • 7-AZONIABICYCLO[2.2.1]HEPTANE DERIVATIVES, METHODS OF PRODUCTION, AND PHARMACEUTICAL USES THEREOF
    Publication number: 20120029044
    Abstract: Muscarinic acetylcholine receptor antagonists and methods of using them for the treatment of muscarinic acetylcholine receptor-mediated diseases, such as pulmonary diseases, are provided.
    Type: Application
    Filed: January 27, 2011
    Publication date: February 2, 2012
    Inventors: Jürg R. Pfister, Gwenaella Rescourio, Meenakshi S. Venkatraman, Xiaoming Zhang
  • Compositions and methods for inhibiting TGF-?
    Patent number: 7943640
    Abstract: The present invention provides compounds of the formula: and pharmaceutically acceptable isomers, salts, hydrates, solvates, and prodrug derivatives thereof, wherein R1, R6, R7, R8, Pg, and n are those defined herein. The present invention also provides pharmaceutical compositions comprising the same and methods for using the same. In particular, compounds of Formula I are useful in modulating TGF-? activity.
    Type: Grant
    Filed: November 16, 2007
    Date of Patent: May 17, 2011
    Assignee: Millenium Pharmaceuticals, Inc.
    Inventors: Anjali Pandey, Robert M. Scarborough, Meenakshi S. Venkatraman
  • 4-SUBSTITUTED QUINUCLIDINE DERIVATIVES, METHODS OF PRODUCTION, AND PHARMACEUTICAL USES THEREOF
    Publication number: 20090088418
    Abstract: The present invention relates to compounds and formulations capable of affecting nicotinic acetylcholine receptors (nAChRs), for example, as modulators of specific nicotinic receptor subtypes (specifically, the alpha7 nAChR subtype). The present invention also relates to methods for treating a wide variety of conditions and disorders, particularly those associated with dysfunction of the central and autonomic nervous systems.
    Type: Application
    Filed: September 30, 2008
    Publication date: April 2, 2009
    Applicant: CoMentis, Inc.
    Inventors: Jurg R. Pfister, Meenakshi S. Venkatraman, Xiaoming Zhang
  • Compositions and methods for inhibiting TGF-?
    Patent number: 7314939
    Abstract: The present invention provides compounds of the formula: and pharmaceutically acceptable isomers, salts, hydrates, solvates, and prodrug derivatives thereof, wherein R1, R6, R7, R8, Pg, and n are those defined herein. The present invention also provides pharmaceutical compositions comprising the same and methods for using the same. In particular, compounds of Formula I are useful in modulating TGF-? activity.
    Type: Grant
    Filed: June 15, 2004
    Date of Patent: January 1, 2008
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Anjali Pandey, Robert M. Scarborough, Meenakshi S. Venkatraman
  • Substituted 2H-1,3-benzoxazin-4(3H)-ones
    Patent number: 7205296
    Abstract: Substituted benzoxazin-4(3H)-ones are provided which are useful for treating thrombosis and for reducing the likelihood and/or severity of a secondary ischemic event in a patient.
    Type: Grant
    Filed: September 26, 2005
    Date of Patent: April 17, 2007
    Assignee: Portola Pharmaceuticals, Inc.
    Inventors: Robert M. Scarborough, Meenakshi S. Venkatraman, Xiaoming Zhang, Anjali Pandey
  • Compositions and methods for inhibiting TGF-?
    Patent number: 7189733
    Abstract: This invention provides compounds that are useful for treating patients having a TGF-?-mediated disease, particularly an ALK5-mediated disease. The compounds are represented by formula I: wherein: a-b is CH2CH2, CH2CH2CH2, CH?CH, CH?N, or N?CH; Z is N or C—F; and G is C1-6 aliphatic or a phenyl, naphthyl, or 5-6 membered heteroaryl ring.
    Type: Grant
    Filed: March 8, 2004
    Date of Patent: March 13, 2007
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Robert M. Scarborough, Anjali Pandey, Meenakshi S. Venkatraman
  • Compositions and methods for inhibiting TGF-beta
    Publication number: 20040204431
    Abstract: This invention provides compounds that are useful for treating patients having a TGF-&bgr;-mediated disease, particularly an ALK5-mediated disease.
    Type: Application
    Filed: March 8, 2004
    Publication date: October 14, 2004
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Robert M. Scarborough, Anjali Pandey, Meenakshi S. Venkatraman